Skip to main content

Table 3 Odds ratios (ORs) with 95% of confidence interval (CI) of metformin-associated lactic acidosis (MALA)-related mortality for potentially predictive factors by univariable and multiple logistic regression

From: Serum lactate level and mortality in metformin-associated lactic acidosis requiring renal replacement therapy: a systematic review of case reports and case series

Variable

Deceased/survivor (total)

Crude analysis

OR (95% CI)

p-value

Multiple-adjustment

OR (95% CI)

(deceased/survivor: 23/152, total = 175)

p-value

Blood lactate (mmol/L)

36/198 (234)

1.08 (1.03, 1.13)

0.001

1.09 (1.02, 1.17)

0.009

Age (yr)

40/212 (252)

0.99 (0.97, 1.01)

0.297

1.03 (0.98, 1.08)

0.236

Sex (ref: male)

41/208 (249)

0.44 (0.22, 0.87)

0.019

0.22 (0.08, 0.67)

0.007

RRT modality

41/210 (251)

    

 IRRT

 

Ref

Ref

 PIRRT

 

1.72 (0.52, 5.70)

0.376

1.28 (0.15, 10.7)

0.818

 CRRT

 

2.36 (1.01, 5.52)

0.048

3.13 (0.81, 12.1)

0.098

 PD

 

9.63 (1.67, 55.8)

0.012

3.11 (0.10, 96.1)

0.517

Metformin usage

36/196 (232)

    

 Suicidal (Ref: regular use)

 

2.19 (1.02, 4.70)

0.044

0.80 (0.15, 4.23)

0.790

Peak creatinine level (mg/dl)

28/183 (211)

0.80 (0.70, 0.91)

0.001

0.77 (0.65, 0.91)

0.003

  1. Abbreviations: CRRT continuous renal replacement therapy, IRRT intermittent renal replacement therapy, PD peritoneal dialysis, PIRRT prolonged intermittent renal replacement therapy, RRT renal replacement therapy